Skip to content Skip to navigation

Provigil Generic Version Antitrust Class Action Settlement

Share
Active: 
Closed
Closed Settlement Statement: 
According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.
Settlement Structure: 
Case Summary: 

The plaintiffs in this lawsuit allege that Cephalon and Teva Pharmaceuticals violated federal and state antitrust laws by delaying the sale of generic, low-cost versions of Provigil.

Docket Number: 
2:16-CV-4234
Company: 
Teva Pharmaceuticals
Class Period: 
Saturday, June 24, 2006 to Saturday, March 31, 2012
Filing Deadline: 
Thursday, April 13, 2017
Objection Deadline: 
Friday, April 14, 2017
Exclusion Deadline: 
Friday, April 14, 2017
Final Approval Hearing: 
Tuesday, July 25, 2017
image of provigil label